id |
pubmed-4114496
|
recordtype |
oai_dc
|
spelling |
pubmed-41144962014-08-01 Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma McGettigan, Suzanne Review Article Harborside Press 2014 2014-05-01 /pmc/articles/PMC4114496/ /pubmed/25089220 Text en Copyright © 2014, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
|
repository_type |
Open Access Journal
|
institution_category |
Foreign Institution
|
institution |
US National Center for Biotechnology Information
|
building |
NCBI PubMed
|
collection |
Online Access
|
language |
English
|
format |
Online
|
author |
McGettigan, Suzanne
|
spellingShingle |
McGettigan, Suzanne
Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
|
author_facet |
McGettigan, Suzanne
|
author_sort |
McGettigan, Suzanne
|
title |
Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
|
title_short |
Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
|
title_full |
Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
|
title_fullStr |
Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
|
title_full_unstemmed |
Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
|
title_sort |
dabrafenib: a new therapy for use in braf-mutated metastatic melanoma
|
description |
|
publisher |
Harborside Press
|
publishDate |
2014
|
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114496/
|
_version_ |
1613118900436729856
|